Cargando…
Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected Subjects
CD4(+) CCR6(+) T cells are highly susceptible to HIV infection, and a high cytokine producing CCR6(+) T cell subset is selectively lost during HIV infection. The CCR6 chemokine MIP-3α (CCL20) is produced at sites of infection in SIV animal models. Recently, we have shown that MIP-3α inhibits HIV rep...
Autores principales: | Zhang, Fuchun, Sun, Lingling, Lafferty, Mark K., Margolick, Joseph B., Garzino-Demo, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778881/ https://www.ncbi.nlm.nih.gov/pubmed/35055955 http://dx.doi.org/10.3390/pathogens11010007 |
Ejemplares similares
-
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6(+)CD4(+) T Cells
por: Lafferty, Mark K., et al.
Publicado: (2017) -
CCR6 mediates the intracellular HIV inhibitory activity of human beta-defensin 2
por: Sun, Lingling, et al.
Publicado: (2006) -
Human beta-defensins induce APOBEC3G expression by interacting with chemokine receptors, protecting highly susceptible cells from HIV infection
por: Garzino-Demo, Alfredo, et al.
Publicado: (2012) -
Parallel dysregulation across psychoimmunological and cardiovascular response systems in HIV+ outpatients
por: Temoshok, Lydia R, et al.
Publicado: (2006) -
Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages
por: Bharucha, Jennifer P., et al.
Publicado: (2021)